DENTSPLY SIRONA Inc. $XRAY Shares Sold by Campbell & CO Investment Adviser LLC

Campbell & CO Investment Adviser LLC cut its stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 67.6% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 58,655 shares of the medical instruments supplier’s stock after selling 122,486 shares during the quarter. Campbell & CO Investment Adviser LLC’s holdings in DENTSPLY SIRONA were worth $744,000 at the end of the most recent quarter.

Other large investors have also made changes to their positions in the company. Public Employees Retirement System of Ohio grew its position in DENTSPLY SIRONA by 1.4% during the second quarter. Public Employees Retirement System of Ohio now owns 61,873 shares of the medical instruments supplier’s stock worth $983,000 after buying an additional 861 shares during the period. True Wealth Design LLC boosted its stake in shares of DENTSPLY SIRONA by 49.7% during the 3rd quarter. True Wealth Design LLC now owns 3,557 shares of the medical instruments supplier’s stock worth $45,000 after acquiring an additional 1,181 shares in the last quarter. Sivia Capital Partners LLC grew its holdings in shares of DENTSPLY SIRONA by 5.3% in the 3rd quarter. Sivia Capital Partners LLC now owns 25,774 shares of the medical instruments supplier’s stock worth $327,000 after acquiring an additional 1,293 shares during the period. AlphaQuest LLC increased its stake in DENTSPLY SIRONA by 2.5% in the 2nd quarter. AlphaQuest LLC now owns 52,817 shares of the medical instruments supplier’s stock valued at $839,000 after purchasing an additional 1,294 shares in the last quarter. Finally, Empowered Funds LLC raised its holdings in DENTSPLY SIRONA by 8.8% during the first quarter. Empowered Funds LLC now owns 16,324 shares of the medical instruments supplier’s stock worth $244,000 after purchasing an additional 1,320 shares during the last quarter. Hedge funds and other institutional investors own 95.70% of the company’s stock.

Analysts Set New Price Targets

Several research firms have weighed in on XRAY. Weiss Ratings reissued a “sell (d-)” rating on shares of DENTSPLY SIRONA in a report on Wednesday, October 8th. Barclays assumed coverage on shares of DENTSPLY SIRONA in a research note on Monday, December 8th. They issued an “underweight” rating and a $12.00 price objective on the stock. Needham & Company LLC restated a “hold” rating on shares of DENTSPLY SIRONA in a research report on Friday, September 26th. Evercore ISI lowered their price target on shares of DENTSPLY SIRONA from $17.00 to $13.00 and set an “in-line” rating on the stock in a research report on Wednesday, October 8th. Finally, Robert W. Baird dropped their price objective on shares of DENTSPLY SIRONA from $14.00 to $12.00 and set a “neutral” rating for the company in a research note on Tuesday, December 16th. Two analysts have rated the stock with a Buy rating, ten have given a Hold rating and three have given a Sell rating to the stock. According to data from MarketBeat, the stock has an average rating of “Reduce” and a consensus target price of $15.23.

DENTSPLY SIRONA Stock Performance

Shares of NASDAQ XRAY opened at $12.05 on Wednesday. The company has a 50-day simple moving average of $11.40 and a 200-day simple moving average of $12.94. The company has a debt-to-equity ratio of 1.36, a current ratio of 1.47 and a quick ratio of 0.99. The company has a market cap of $2.40 billion, a PE ratio of -2.73, a price-to-earnings-growth ratio of 0.94 and a beta of 1.00. DENTSPLY SIRONA Inc. has a 12 month low of $9.85 and a 12 month high of $20.59.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its earnings results on Thursday, November 6th. The medical instruments supplier reported $0.37 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.45 by ($0.08). The firm had revenue of $904.00 million for the quarter, compared to analyst estimates of $900.33 million. DENTSPLY SIRONA had a positive return on equity of 17.10% and a negative net margin of 24.34%.The firm’s revenue was down 4.9% compared to the same quarter last year. During the same quarter last year, the business posted $0.50 EPS. DENTSPLY SIRONA has set its FY 2025 guidance at 1.600-1.600 EPS. On average, equities analysts anticipate that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current year.

DENTSPLY SIRONA Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, January 9th. Shareholders of record on Friday, December 26th were issued a $0.16 dividend. The ex-dividend date was Friday, December 26th. This represents a $0.64 annualized dividend and a yield of 5.3%. DENTSPLY SIRONA’s payout ratio is -14.48%.

Insider Buying and Selling at DENTSPLY SIRONA

In other news, Director Gregory T. Lucier sold 82,200 shares of the stock in a transaction dated Monday, December 8th. The shares were sold at an average price of $11.14, for a total transaction of $915,708.00. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.52% of the stock is currently owned by insiders.

About DENTSPLY SIRONA

Dentsply Sirona Inc (NASDAQ: XRAY) is a leading global manufacturer of professional dental products and technologies. The company, formed through the merger of Dentsply International and Sirona Dental Systems in February 2016, brings together a long heritage of innovation in dental care. Headquartered in Charlotte, North Carolina, Dentsply Sirona develops and markets a comprehensive range of dental consumables, laboratory products, and advanced imaging and CAD/CAM systems.

The company’s product portfolio spans preventive, restorative, orthodontic, endodontic and surgical care.